Cargando…

IF-03 Clinical Effectiveness of Oseltamivir or Zanamivir for Influenza A/H1N1 Virus with or without H274Y Mutation

Detalles Bibliográficos
Autores principales: Kawai, Naoki, Ikematsu, Hideyuki, Iwaki, Norio, Kashiwagi, Seizaburo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Infectious Diseases. Published by Elsevier Ltd. 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129484/
http://dx.doi.org/10.1016/S1201-9712(09)60318-0
_version_ 1783516796086648832
author Kawai, Naoki
Ikematsu, Hideyuki
Iwaki, Norio
Kashiwagi, Seizaburo
author_facet Kawai, Naoki
Ikematsu, Hideyuki
Iwaki, Norio
Kashiwagi, Seizaburo
author_sort Kawai, Naoki
collection PubMed
description
format Online
Article
Text
id pubmed-7129484
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher International Society for Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71294842020-04-08 IF-03 Clinical Effectiveness of Oseltamivir or Zanamivir for Influenza A/H1N1 Virus with or without H274Y Mutation Kawai, Naoki Ikematsu, Hideyuki Iwaki, Norio Kashiwagi, Seizaburo Int J Infect Dis Article International Society for Infectious Diseases. Published by Elsevier Ltd. 2009-08 2009-08-13 /pmc/articles/PMC7129484/ http://dx.doi.org/10.1016/S1201-9712(09)60318-0 Text en © 2009 International Society for Infectious Diseases Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Kawai, Naoki
Ikematsu, Hideyuki
Iwaki, Norio
Kashiwagi, Seizaburo
IF-03 Clinical Effectiveness of Oseltamivir or Zanamivir for Influenza A/H1N1 Virus with or without H274Y Mutation
title IF-03 Clinical Effectiveness of Oseltamivir or Zanamivir for Influenza A/H1N1 Virus with or without H274Y Mutation
title_full IF-03 Clinical Effectiveness of Oseltamivir or Zanamivir for Influenza A/H1N1 Virus with or without H274Y Mutation
title_fullStr IF-03 Clinical Effectiveness of Oseltamivir or Zanamivir for Influenza A/H1N1 Virus with or without H274Y Mutation
title_full_unstemmed IF-03 Clinical Effectiveness of Oseltamivir or Zanamivir for Influenza A/H1N1 Virus with or without H274Y Mutation
title_short IF-03 Clinical Effectiveness of Oseltamivir or Zanamivir for Influenza A/H1N1 Virus with or without H274Y Mutation
title_sort if-03 clinical effectiveness of oseltamivir or zanamivir for influenza a/h1n1 virus with or without h274y mutation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129484/
http://dx.doi.org/10.1016/S1201-9712(09)60318-0
work_keys_str_mv AT kawainaoki if03clinicaleffectivenessofoseltamivirorzanamivirforinfluenzaah1n1viruswithorwithouth274ymutation
AT ikematsuhideyuki if03clinicaleffectivenessofoseltamivirorzanamivirforinfluenzaah1n1viruswithorwithouth274ymutation
AT iwakinorio if03clinicaleffectivenessofoseltamivirorzanamivirforinfluenzaah1n1viruswithorwithouth274ymutation
AT kashiwagiseizaburo if03clinicaleffectivenessofoseltamivirorzanamivirforinfluenzaah1n1viruswithorwithouth274ymutation